BR0200414A - Sulfonamidas como inibidores de metaloproteinase da matriz - Google Patents

Sulfonamidas como inibidores de metaloproteinase da matriz

Info

Publication number
BR0200414A
BR0200414A BR0200414-3A BR0200414A BR0200414A BR 0200414 A BR0200414 A BR 0200414A BR 0200414 A BR0200414 A BR 0200414A BR 0200414 A BR0200414 A BR 0200414A
Authority
BR
Brazil
Prior art keywords
matrix metalloproteinase
sulfonamides
metalloproteinase inhibitors
alkyl
hydrogen
Prior art date
Application number
BR0200414-3A
Other languages
English (en)
Inventor
Patrick Michael O'brien
William Chester Patt
Joseph Armand Picard
Kevon Ray Shuler
Drago Robert Sliskovic
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0200414A publication Critical patent/BR0200414A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"SULFONAMIDAS COMO INIBIDORES DE METALOPROTEINASE DA MATRIZ". Os inibidores da metaloproteinase da matriz são sulfonamidas tricíclicas substituídas da fórmula ou de um sal farmaceuticamente aceitável resultante em que R^ 1^ e R^ 2^ incluem hidrogênio, alquilo, e alquilo substituído; R^ 3^ e R^ 4^ incluem hidrogênio, alquilo, e alquilo substituído; R^ 3^ e R^ 4^ incluem hidrogênio, halogênio e alquilo; X é OH ou NHOH, V é O, S, SO~ 2~, NR^ 5^, ou CH~ 2~, R^ 5^ é um hidrogênio ou alquilo, e Z é (CH~ 2~)n, em que n é um número inteiro desde 0 a 2.
BR0200414-3A 2001-02-14 2002-02-08 Sulfonamidas como inibidores de metaloproteinase da matriz BR0200414A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26873701P 2001-02-14 2001-02-14

Publications (1)

Publication Number Publication Date
BR0200414A true BR0200414A (pt) 2003-04-29

Family

ID=23024247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0200414-3A BR0200414A (pt) 2001-02-14 2002-02-08 Sulfonamidas como inibidores de metaloproteinase da matriz

Country Status (8)

Country Link
US (1) US6559142B2 (pt)
EP (1) EP1233017B1 (pt)
JP (1) JP2002308859A (pt)
AT (1) ATE312829T1 (pt)
BR (1) BR0200414A (pt)
CA (1) CA2371481A1 (pt)
DE (1) DE60207913D1 (pt)
MX (1) MXPA01013172A (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US8088737B2 (en) 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
JP2010507674A (ja) * 2006-10-27 2010-03-11 ワイス エルエルシー マトリクスメタロプロテアーゼ阻害剤としての三環式化合物
US9408816B2 (en) * 2006-12-26 2016-08-09 Pharmacyclics Llc Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
PE20090223A1 (es) * 2007-05-04 2009-03-08 Wyeth Corp Compuestos triciclicos como inhibidores de metaloproteinasas matriciales
JP6330118B2 (ja) 2011-09-13 2018-05-30 ファーマサイクリックス エルエルシー ベンダムスチンと組み合わせたヒストンデアセチラーゼ阻害剤の製剤とその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207672B1 (en) 1995-11-13 2001-03-27 Aventis Pharma Deutschland Gmbh Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
US6008243A (en) 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
KR20000057444A (ko) 1996-12-09 2000-09-15 로즈 암스트롱, 크리스틴 에이. 트러트웨인 심기능부전 및 심실확장의 치료 및 예방 방법
EP0960098A1 (en) 1997-02-11 1999-12-01 Pfizer Inc. Arylsulfonyl hydroxamic acid derivatives
US6934639B1 (en) 2000-02-25 2005-08-23 Wyeth Methods for designing agents that interact with MMP-13

Also Published As

Publication number Publication date
US6559142B2 (en) 2003-05-06
CA2371481A1 (en) 2002-08-14
EP1233017B1 (en) 2005-12-14
US20020169160A1 (en) 2002-11-14
ATE312829T1 (de) 2005-12-15
EP1233017A1 (en) 2002-08-21
JP2002308859A (ja) 2002-10-23
DE60207913D1 (de) 2006-01-19
MXPA01013172A (es) 2002-08-21

Similar Documents

Publication Publication Date Title
NO20023457D0 (no) Nye piperidinforbindelser og legemidler inneholdende de samme
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
UY27155A1 (es) Inhibidores de benzotiadiazina de metaloproteinasas de la matriz
AR051778A2 (es) Derivados del acido dimetilaminocrotonico y procesos para supreparacion
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
BR0207302A (pt) Trifluorometilpurinas como inibidores da fosfodiesterase 4
EP1371640A4 (en) NEW A-LIPONIC ACID DERIVATIVE AND ITS USE
ATE352555T1 (de) Perindopril
NO20061872L (no) Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
NO20026014L (no) Vitamin D-derivater
ATE161254T1 (de) Benzopyranderivat
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
BR0200414A (pt) Sulfonamidas como inibidores de metaloproteinase da matriz
DE60223904D1 (de) Benzylaminanalogen
DE60013560D1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
DK1312608T3 (da) Discodermolid-analoge samt deres farmaceutiske anvendelse
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
TW200508211A (en) 2-naphthylimino-1,3-thiazine derivatives
DE60211686D1 (de) Pkb-3564-substanz mit die gefässneubildung hemmender wirkung
BR0200476A (pt) Bifenilsulfonamidas tricìclicas como inibidores de metaloproteinase da matriz
DE60230924D1 (de) 2-substituierte vitamin-d-derivate
NO20010244D0 (no) Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008.